Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tlx2
|
ENSMUSG00000068327.3 | T cell leukemia, homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_83071355_83071594 | Tlx2 | 1181 | 0.174172 | -0.35 | 9.9e-03 | Click! |
chr6_83070368_83070519 | Tlx2 | 150 | 0.836985 | -0.26 | 5.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_16073322_16073836 | 52.50 |
4930444P10Rik |
RIKEN cDNA 4930444P10 gene |
7633 |
0.17 |
chr16_11423409_11423900 | 34.05 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr1_16073908_16074338 | 29.74 |
4930444P10Rik |
RIKEN cDNA 4930444P10 gene |
7089 |
0.18 |
chr6_87740576_87740855 | 11.82 |
Efcc1 |
EF hand and coiled-coil domain containing 1 |
7906 |
0.09 |
chr6_114659890_114660158 | 11.42 |
Atg7 |
autophagy related 7 |
1960 |
0.4 |
chr11_48855844_48857180 | 10.56 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chrX_136135584_136135889 | 10.39 |
Bex4 |
brain expressed X-linked 4 |
3260 |
0.16 |
chr11_78073909_78074294 | 8.59 |
Mir451b |
microRNA 451b |
860 |
0.24 |
chr15_66825863_66826251 | 8.52 |
Sla |
src-like adaptor |
5589 |
0.21 |
chr9_107971775_107971975 | 8.26 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3630 |
0.07 |
chr9_53422571_53422732 | 8.13 |
4930550C14Rik |
RIKEN cDNA 4930550C14 gene |
17353 |
0.14 |
chr7_24371478_24371804 | 8.08 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1303 |
0.24 |
chr8_94787524_94787757 | 8.07 |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
15415 |
0.1 |
chr3_14886091_14887033 | 7.74 |
Car2 |
carbonic anhydrase 2 |
77 |
0.97 |
chr17_5093326_5093711 | 7.47 |
Gm15599 |
predicted gene 15599 |
18592 |
0.23 |
chr5_147492662_147492929 | 7.33 |
Pan3 |
PAN3 poly(A) specific ribonuclease subunit |
24707 |
0.13 |
chr6_67161663_67162061 | 7.27 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr1_38011634_38011926 | 6.98 |
Eif5b |
eukaryotic translation initiation factor 5B |
13651 |
0.14 |
chr4_62516613_62516900 | 6.81 |
Alad |
aminolevulinate, delta-, dehydratase |
3125 |
0.15 |
chr5_34881199_34881391 | 6.56 |
Htt |
huntingtin |
4103 |
0.22 |
chr11_117780842_117781082 | 6.52 |
Tmc6 |
transmembrane channel-like gene family 6 |
18 |
0.93 |
chr11_44508913_44509245 | 6.37 |
Rnf145 |
ring finger protein 145 |
9885 |
0.16 |
chr5_143561547_143562201 | 6.37 |
Fam220a |
family with sequence similarity 220, member A |
12834 |
0.14 |
chr6_72389979_72390703 | 6.36 |
Vamp8 |
vesicle-associated membrane protein 8 |
362 |
0.76 |
chr17_40812191_40812348 | 6.34 |
Rhag |
Rhesus blood group-associated A glycoprotein |
1085 |
0.44 |
chr5_33542035_33542598 | 6.27 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr11_83224251_83224525 | 6.23 |
Gm11427 |
predicted gene 11427 |
66 |
0.72 |
chr5_139803700_139803926 | 6.15 |
Tmem184a |
transmembrane protein 184a |
4167 |
0.14 |
chr11_49088403_49088584 | 6.09 |
Gm12188 |
predicted gene 12188 |
50 |
0.71 |
chr5_139734496_139734696 | 6.03 |
Micall2 |
MICAL-like 2 |
1740 |
0.28 |
chr1_24613351_24614205 | 6.03 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr10_30763229_30763567 | 5.97 |
Gm48334 |
predicted gene, 48334 |
6177 |
0.15 |
chr7_103915106_103915263 | 5.96 |
Olfr65 |
olfactory receptor 65 |
8842 |
0.06 |
chr11_87368253_87368600 | 5.89 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr2_173032812_173033942 | 5.86 |
Gm14453 |
predicted gene 14453 |
1203 |
0.38 |
chr19_47403543_47403739 | 5.79 |
Sh3pxd2a |
SH3 and PX domains 2A |
6718 |
0.23 |
chr11_90727827_90728134 | 5.77 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39614 |
0.15 |
chr18_56870554_56870904 | 5.75 |
Gm18087 |
predicted gene, 18087 |
45359 |
0.14 |
chr6_41703736_41703887 | 5.74 |
Kel |
Kell blood group |
528 |
0.68 |
chr10_80858589_80858921 | 5.74 |
Sppl2b |
signal peptide peptidase like 2B |
1634 |
0.17 |
chr2_121235536_121235693 | 5.71 |
Trp53bp1 |
transformation related protein 53 binding protein 1 |
75 |
0.96 |
chr11_95777553_95777757 | 5.71 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
16164 |
0.12 |
chr9_90237740_90238196 | 5.66 |
Gm16200 |
predicted gene 16200 |
16343 |
0.15 |
chr16_49800061_49800448 | 5.65 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
279 |
0.89 |
chr1_161894176_161894553 | 5.62 |
Gm31925 |
predicted gene, 31925 |
2217 |
0.25 |
chr8_70201410_70201576 | 5.58 |
Slc25a42 |
solute carrier family 25, member 42 |
10763 |
0.09 |
chr3_96559637_96560168 | 5.53 |
Txnip |
thioredoxin interacting protein |
152 |
0.87 |
chr7_44777278_44777454 | 5.52 |
Gm29791 |
predicted gene, 29791 |
13282 |
0.08 |
chr2_6284874_6285049 | 5.51 |
Gm13383 |
predicted gene 13383 |
27695 |
0.14 |
chr7_141770985_141771320 | 5.51 |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
17820 |
0.15 |
chrX_159757373_159757549 | 5.43 |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
48860 |
0.17 |
chr3_100547143_100547441 | 5.42 |
Gm43466 |
predicted gene 43466 |
40235 |
0.11 |
chr2_125900873_125901039 | 5.41 |
Galk2 |
galactokinase 2 |
34688 |
0.17 |
chr13_23697544_23698095 | 5.37 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr19_6969291_6970359 | 5.32 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr15_10399752_10400222 | 5.31 |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
41408 |
0.13 |
chr1_75445167_75446076 | 5.30 |
Gmppa |
GDP-mannose pyrophosphorylase A |
3397 |
0.11 |
chr7_100466963_100467472 | 5.23 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr4_132269873_132270275 | 5.19 |
Gm28872 |
predicted gene 28872 |
18 |
0.62 |
chr1_16072548_16072766 | 5.15 |
4930444P10Rik |
RIKEN cDNA 4930444P10 gene |
8555 |
0.17 |
chr6_120011092_120011253 | 5.14 |
Gm16199 |
predicted gene 16199 |
5174 |
0.19 |
chr9_98297973_98298148 | 5.12 |
Nmnat3 |
nicotinamide nucleotide adenylyltransferase 3 |
1398 |
0.44 |
chr10_68446597_68447155 | 5.10 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
78891 |
0.09 |
chr12_103636052_103636230 | 5.09 |
Serpina10 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
4697 |
0.13 |
chr7_141132187_141132543 | 5.02 |
Ptdss2 |
phosphatidylserine synthase 2 |
73 |
0.93 |
chr4_46407404_46407574 | 5.02 |
Hemgn |
hemogen |
3253 |
0.17 |
chrX_11664322_11665096 | 5.01 |
Gm14513 |
predicted gene 14513 |
19415 |
0.24 |
chr5_143819015_143819332 | 5.01 |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
1226 |
0.42 |
chr19_55861702_55862045 | 5.00 |
Ppnr |
per-pentamer repeat gene |
20201 |
0.22 |
chr11_85843373_85844045 | 4.99 |
Gm11444 |
predicted gene 11444 |
6624 |
0.13 |
chr11_102352343_102352811 | 4.97 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
7991 |
0.1 |
chr15_38542818_38543018 | 4.96 |
Azin1 |
antizyme inhibitor 1 |
23652 |
0.1 |
chr17_28803390_28803555 | 4.95 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
1688 |
0.2 |
chr15_82164544_82164745 | 4.93 |
Srebf2 |
sterol regulatory element binding factor 2 |
16619 |
0.09 |
chr9_123678850_123679043 | 4.93 |
Slc6a20a |
solute carrier family 6 (neurotransmitter transporter), member 20A |
61 |
0.84 |
chr7_127767648_127767812 | 4.92 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
2085 |
0.13 |
chr19_10173573_10173745 | 4.91 |
Gm50359 |
predicted gene, 50359 |
2502 |
0.16 |
chr15_80911293_80911475 | 4.89 |
Tnrc6b |
trinucleotide repeat containing 6b |
4532 |
0.18 |
chr17_53596429_53596797 | 4.86 |
Gm6919 |
predicted gene 6919 |
2050 |
0.27 |
chr8_94966621_94966796 | 4.86 |
Gm10286 |
predicted gene 10286 |
3046 |
0.16 |
chr6_108529607_108529783 | 4.85 |
Gm44040 |
predicted gene, 44040 |
4008 |
0.18 |
chr19_8947047_8947218 | 4.85 |
Mta2 |
metastasis-associated gene family, member 2 |
732 |
0.37 |
chr18_70530231_70530511 | 4.83 |
Poli |
polymerase (DNA directed), iota |
63 |
0.97 |
chr11_95356559_95356764 | 4.82 |
Fam117a |
family with sequence similarity 117, member A |
16699 |
0.11 |
chr7_35350340_35350583 | 4.80 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
16131 |
0.13 |
chr11_87756139_87756345 | 4.77 |
Mir142 |
microRNA 142 |
622 |
0.29 |
chr4_110230095_110230256 | 4.75 |
Elavl4 |
ELAV like RNA binding protein 4 |
7027 |
0.32 |
chr12_105025367_105025529 | 4.74 |
Gm47650 |
predicted gene, 47650 |
2515 |
0.15 |
chr7_4613779_4614054 | 4.73 |
Gm18973 |
predicted gene, 18973 |
751 |
0.37 |
chr13_23498744_23499110 | 4.72 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
10070 |
0.06 |
chr6_72273266_72273430 | 4.72 |
Sftpb |
surfactant associated protein B |
31262 |
0.11 |
chr1_130462159_130462617 | 4.67 |
Cd55 |
CD55 molecule, decay accelerating factor for complement |
63 |
0.67 |
chr5_75450662_75450882 | 4.62 |
Gm42800 |
predicted gene 42800 |
51400 |
0.13 |
chr2_32061809_32061973 | 4.62 |
Gm16534 |
predicted gene 16534 |
2273 |
0.17 |
chr14_69321459_69321646 | 4.60 |
Gm16677 |
predicted gene, 16677 |
15530 |
0.09 |
chr14_69539708_69539896 | 4.60 |
Gm27174 |
predicted gene 27174 |
15530 |
0.09 |
chr11_109557821_109558079 | 4.57 |
Arsg |
arylsulfatase G |
14196 |
0.16 |
chr9_61370339_61371660 | 4.54 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr17_71238518_71238794 | 4.53 |
Lpin2 |
lipin 2 |
6 |
0.97 |
chr2_127369776_127369952 | 4.53 |
Adra2b |
adrenergic receptor, alpha 2b |
6578 |
0.15 |
chr7_101064633_101064988 | 4.52 |
Gm5735 |
predicted gene 5735 |
3335 |
0.2 |
chr8_84702030_84702302 | 4.50 |
Lyl1 |
lymphoblastomic leukemia 1 |
385 |
0.72 |
chr3_103171228_103172264 | 4.49 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr11_108424530_108425250 | 4.49 |
Cep112 |
centrosomal protein 112 |
302 |
0.86 |
chr4_140860843_140861012 | 4.48 |
4930515B02Rik |
RIKEN cDNA 4930515B02 gene |
11766 |
0.12 |
chr16_20702522_20702892 | 4.46 |
Clcn2 |
chloride channel, voltage-sensitive 2 |
6027 |
0.08 |
chr11_95823907_95824556 | 4.45 |
Phospho1 |
phosphatase, orphan 1 |
268 |
0.85 |
chr1_36095507_36096003 | 4.45 |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
5935 |
0.15 |
chr8_120372171_120372550 | 4.44 |
Gm22715 |
predicted gene, 22715 |
71189 |
0.09 |
chr11_74575887_74576243 | 4.43 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
14059 |
0.18 |
chr8_36668721_36669167 | 4.43 |
Dlc1 |
deleted in liver cancer 1 |
55001 |
0.16 |
chr10_128625984_128626561 | 4.42 |
Rps26 |
ribosomal protein S26 |
152 |
0.88 |
chr7_135816621_135817118 | 4.37 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
36813 |
0.12 |
chr11_95808504_95808830 | 4.36 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr5_139380266_139381195 | 4.36 |
Gpr146 |
G protein-coupled receptor 146 |
149 |
0.92 |
chr10_80579002_80579213 | 4.36 |
Klf16 |
Kruppel-like factor 16 |
1786 |
0.15 |
chr5_151418628_151418887 | 4.34 |
Gm42906 |
predicted gene 42906 |
9406 |
0.16 |
chr6_90624916_90625133 | 4.27 |
Slc41a3 |
solute carrier family 41, member 3 |
5877 |
0.15 |
chr13_24419481_24419859 | 4.26 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2446 |
0.22 |
chr1_14484193_14484345 | 4.25 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
174034 |
0.03 |
chr19_53194450_53194618 | 4.22 |
Add3 |
adducin 3 (gamma) |
419 |
0.82 |
chr11_4543069_4543227 | 4.22 |
Mtmr3 |
myotubularin related protein 3 |
3120 |
0.23 |
chr19_53257764_53258020 | 4.20 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
2672 |
0.22 |
chr17_65557305_65557480 | 4.19 |
Gm49866 |
predicted gene, 49866 |
3384 |
0.19 |
chrX_123721926_123722462 | 4.15 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr15_75886612_75887093 | 4.15 |
Mroh6 |
maestro heat-like repeat family member 6 |
1918 |
0.15 |
chr7_128398591_128399004 | 4.14 |
Rgs10 |
regulator of G-protein signalling 10 |
5112 |
0.13 |
chr13_9426283_9426644 | 4.12 |
Gm48889 |
predicted gene, 48889 |
13946 |
0.16 |
chr17_28832918_28833228 | 4.11 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
4991 |
0.11 |
chr19_46304500_46305228 | 4.10 |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
64 |
0.9 |
chr4_134165911_134166062 | 4.10 |
Gm27619 |
predicted gene, 27619 |
1909 |
0.19 |
chr14_41008142_41008410 | 4.09 |
Prxl2a |
peroxiredoxin like 2A |
10 |
0.97 |
chr1_37884551_37884702 | 4.09 |
Mitd1 |
MIT, microtubule interacting and transport, domain containing 1 |
2758 |
0.16 |
chr2_156924623_156924803 | 4.08 |
Gm14278 |
predicted gene 14278 |
9330 |
0.1 |
chr10_118064868_118065238 | 4.08 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
47464 |
0.11 |
chr19_29135203_29135662 | 4.06 |
Mir101b |
microRNA 101b |
153 |
0.94 |
chr4_35125058_35125826 | 4.06 |
Ifnk |
interferon kappa |
26614 |
0.16 |
chrX_123943434_123943951 | 4.04 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr12_40027574_40027739 | 4.02 |
Arl4a |
ADP-ribosylation factor-like 4A |
9711 |
0.19 |
chr6_58648523_58648684 | 4.00 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
8021 |
0.23 |
chr11_102218354_102219649 | 3.99 |
Hdac5 |
histone deacetylase 5 |
72 |
0.94 |
chr9_103288790_103289055 | 3.99 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
625 |
0.69 |
chr1_156721875_156722217 | 3.99 |
Fam20b |
family with sequence similarity 20, member B |
2960 |
0.23 |
chr18_82523055_82523247 | 3.98 |
Rpl21-ps8 |
ribosomal protein L21, pseudogene 8 |
870 |
0.6 |
chr9_66182054_66182393 | 3.98 |
Dapk2 |
death-associated protein kinase 2 |
23988 |
0.17 |
chr13_91474145_91474307 | 3.98 |
Ssbp2 |
single-stranded DNA binding protein 2 |
13045 |
0.25 |
chr10_94913371_94913538 | 3.97 |
Plxnc1 |
plexin C1 |
9203 |
0.2 |
chr12_76241275_76241437 | 3.96 |
Tex21 |
testis expressed gene 21 |
5329 |
0.14 |
chr15_79685444_79685886 | 3.96 |
Josd1 |
Josephin domain containing 1 |
2254 |
0.13 |
chr19_45016824_45017769 | 3.96 |
Lzts2 |
leucine zipper, putative tumor suppressor 2 |
799 |
0.44 |
chr5_67815566_67815778 | 3.95 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
181 |
0.93 |
chr11_22913835_22914100 | 3.94 |
Commd1 |
COMM domain containing 1 |
42980 |
0.08 |
chr13_23544226_23545176 | 3.94 |
H3c7 |
H3 clustered histone 7 |
649 |
0.31 |
chrX_123271195_123271712 | 3.94 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr14_64193921_64194220 | 3.91 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
77756 |
0.08 |
chrX_123500550_123501093 | 3.91 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr4_119036970_119037397 | 3.91 |
Gm12866 |
predicted gene 12866 |
31928 |
0.08 |
chr1_24612739_24612914 | 3.89 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chr17_43025131_43025438 | 3.88 |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
8716 |
0.29 |
chr12_3286042_3286208 | 3.88 |
Rab10 |
RAB10, member RAS oncogene family |
23844 |
0.14 |
chr19_61266773_61267173 | 3.87 |
Gm50357 |
predicted gene, 50357 |
9184 |
0.13 |
chr2_152406114_152406779 | 3.87 |
Sox12 |
SRY (sex determining region Y)-box 12 |
8383 |
0.08 |
chr7_96781497_96781682 | 3.87 |
Tenm4 |
teneurin transmembrane protein 4 |
3655 |
0.21 |
chr10_81092585_81092876 | 3.86 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
155 |
0.88 |
chr7_64012058_64012232 | 3.85 |
Gm32633 |
predicted gene, 32633 |
4376 |
0.18 |
chr1_161791932_161792113 | 3.84 |
Fasl |
Fas ligand (TNF superfamily, member 6) |
3527 |
0.17 |
chr4_141537813_141538641 | 3.84 |
Spen |
spen family transcription repressor |
26 |
0.97 |
chr9_109059177_109059408 | 3.84 |
Trex1 |
three prime repair exonuclease 1 |
41 |
0.92 |
chr4_116720426_116721428 | 3.83 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr8_122618682_122618964 | 3.82 |
Mir6396 |
microRNA 6396 |
3552 |
0.11 |
chr14_63130761_63130912 | 3.82 |
Ctsb |
cathepsin B |
4682 |
0.15 |
chr10_128804096_128805293 | 3.77 |
Tmem198b |
transmembrane protein 198b |
324 |
0.61 |
chr5_148980661_148980947 | 3.75 |
Gm42791 |
predicted gene 42791 |
289 |
0.79 |
chr17_58925181_58925410 | 3.74 |
Pdzph1 |
PDZ and pleckstrin homology domains 1 |
31800 |
0.19 |
chr11_62006277_62006428 | 3.74 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
1002 |
0.52 |
chr10_94249569_94249879 | 3.74 |
Gm4792 |
predicted gene 4792 |
48979 |
0.1 |
chr11_62605415_62606716 | 3.73 |
Lrrc75aos2 |
leucine rich repeat containing 75A, opposite strand 2 |
298 |
0.72 |
chr8_35205759_35205935 | 3.71 |
Gm34474 |
predicted gene, 34474 |
12791 |
0.14 |
chr7_63991312_63991600 | 3.71 |
Gm32633 |
predicted gene, 32633 |
10429 |
0.14 |
chr17_63311771_63311933 | 3.70 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
1119 |
0.54 |
chrX_142680720_142682167 | 3.70 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr13_97766979_97767130 | 3.69 |
Rps18-ps6 |
ribosomal protein S18, pseudogene 6 |
6422 |
0.16 |
chr1_129956505_129956749 | 3.68 |
Gm37278 |
predicted gene, 37278 |
13465 |
0.22 |
chr19_17355480_17355635 | 3.68 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1110 |
0.57 |
chr14_32165572_32165888 | 3.68 |
Ncoa4 |
nuclear receptor coactivator 4 |
61 |
0.95 |
chr11_100938783_100940230 | 3.67 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr4_86886186_86886590 | 3.66 |
Acer2 |
alkaline ceramidase 2 |
11974 |
0.21 |
chr10_117149996_117150287 | 3.64 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
1607 |
0.3 |
chr2_74847070_74847233 | 3.64 |
Gm14425 |
predicted gene 14425 |
8555 |
0.13 |
chr7_103874539_103874695 | 3.63 |
Olfr66 |
olfactory receptor 66 |
7624 |
0.06 |
chr11_85339500_85339819 | 3.62 |
Bcas3 |
breast carcinoma amplified sequence 3 |
13508 |
0.19 |
chr4_88536264_88536429 | 3.62 |
Ifnb1 |
interferon beta 1, fibroblast |
13572 |
0.1 |
chr18_42262448_42262930 | 3.62 |
Lars |
leucyl-tRNA synthetase |
495 |
0.7 |
chr14_116946057_116946269 | 3.61 |
Gpc6 |
glypican 6 |
20227 |
0.3 |
chr18_82474598_82476191 | 3.61 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr7_132772149_132772433 | 3.61 |
Fam53b |
family with sequence similarity 53, member B |
4625 |
0.23 |
chr6_123207279_123207450 | 3.59 |
Gm22946 |
predicted gene, 22946 |
11651 |
0.12 |
chr9_32559988_32560144 | 3.58 |
Fli1 |
Friend leukemia integration 1 |
17205 |
0.12 |
chr7_128298500_128298671 | 3.57 |
BC017158 |
cDNA sequence BC017158 |
415 |
0.71 |
chr7_96959235_96959424 | 3.57 |
C230038L03Rik |
RIKEN cDNA C230038L03 gene |
7443 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:0042938 | dipeptide transport(GO:0042938) |
2.8 | 11.4 | GO:0008228 | opsonization(GO:0008228) |
2.2 | 2.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.2 | 6.7 | GO:0036394 | amylase secretion(GO:0036394) |
2.1 | 10.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
1.8 | 7.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
1.7 | 8.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.7 | 5.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.6 | 6.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.5 | 4.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.5 | 4.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.5 | 4.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.5 | 11.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.4 | 5.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.4 | 4.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.4 | 14.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.4 | 2.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.4 | 5.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.3 | 5.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.3 | 3.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.3 | 5.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.3 | 3.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.3 | 5.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.2 | 5.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.2 | 2.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.2 | 4.8 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.2 | 3.6 | GO:0040031 | snRNA modification(GO:0040031) |
1.2 | 5.9 | GO:0070627 | ferrous iron import(GO:0070627) |
1.2 | 2.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.2 | 3.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 3.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.1 | 5.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.1 | 3.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.1 | 3.3 | GO:1902896 | terminal web assembly(GO:1902896) |
1.1 | 3.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.1 | 1.1 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.1 | 3.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.1 | 8.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.0 | 4.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.0 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.0 | 3.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.0 | 2.0 | GO:0044531 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
1.0 | 3.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 1.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.0 | 1.0 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.0 | 2.9 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 3.8 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.9 | 0.9 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.9 | 2.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.9 | 0.9 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.9 | 2.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 2.8 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.9 | 0.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.9 | 2.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.9 | 4.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 9.2 | GO:0000050 | urea cycle(GO:0000050) |
0.9 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 1.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.9 | 3.6 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.9 | 3.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.9 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 1.7 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.9 | 0.9 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.9 | 2.6 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.9 | 2.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.9 | 4.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.9 | 5.2 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.8 | 3.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.8 | 1.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.8 | 2.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 5.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.8 | 2.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.8 | 3.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.8 | 2.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 3.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 3.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 2.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 2.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.8 | 3.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 4.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.8 | 3.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.8 | 1.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 3.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.8 | 2.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.8 | 3.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 3.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 4.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.7 | 4.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.7 | 2.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 4.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 2.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.7 | 2.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.7 | 2.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.7 | 2.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.7 | 0.7 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.7 | 2.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 3.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 1.4 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.7 | 0.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.7 | 1.4 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 1.4 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.7 | 2.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.7 | 2.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 4.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 3.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 2.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.6 | 3.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.6 | 1.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 3.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 1.3 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.6 | 1.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 1.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 2.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.6 | 0.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.6 | 1.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 0.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.6 | 3.7 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.6 | 2.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 0.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.6 | 4.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.6 | 0.6 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.6 | 2.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.6 | 5.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 1.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 1.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.6 | 12.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 3.0 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 8.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 1.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 2.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.6 | 1.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 1.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 2.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 1.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.6 | 2.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 5.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 2.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 1.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.6 | 1.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.6 | 3.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 8.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.6 | 3.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 1.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 1.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 3.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 2.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.5 | 2.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 1.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 2.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.5 | 1.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 1.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 0.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 4.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.5 | 1.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 2.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 1.0 | GO:0032782 | bile acid secretion(GO:0032782) |
0.5 | 2.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 5.6 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.5 | 4.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.5 | 2.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 1.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 6.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.5 | 4.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 2.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 2.5 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.5 | 2.5 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 3.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.5 | 1.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 3.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.5 | 1.0 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 0.5 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.5 | 6.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.5 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 2.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 2.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 3.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 1.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 1.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 6.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.5 | 1.9 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.5 | 1.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 1.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 1.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 2.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.5 | 2.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 1.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 0.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 3.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 1.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.5 | 0.5 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.5 | 0.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.5 | 4.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 3.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 2.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 5.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 1.8 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 1.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 1.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 0.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 1.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 2.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 8.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 1.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 2.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 0.5 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.5 | 5.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 1.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.4 | 3.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 6.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 5.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.4 | 1.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 4.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 0.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 1.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 0.9 | GO:0042373 | menaquinone metabolic process(GO:0009233) vitamin K metabolic process(GO:0042373) |
0.4 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 2.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 1.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.4 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 3.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 1.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 0.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.4 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 1.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 2.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 1.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 1.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 1.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 0.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.4 | 0.8 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 2.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 4.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 2.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 0.8 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.4 | 2.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 1.6 | GO:0046618 | drug export(GO:0046618) |
0.4 | 1.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.8 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.4 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.4 | 0.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.4 | 1.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 0.8 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.4 | 1.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.4 | 1.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 0.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.4 | 1.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 2.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 1.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.4 | 0.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.4 | 0.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.4 | 1.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.4 | 2.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
0.4 | 3.9 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.4 | 0.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 0.8 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 0.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 1.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 0.8 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.4 | 0.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 0.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 3.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 0.8 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.4 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 4.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 1.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.4 | 2.3 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.4 | 0.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.1 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.4 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 2.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 0.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 4.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 1.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 3.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.4 | 0.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.4 | 0.7 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 1.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.8 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 1.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 0.7 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.4 | 0.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.4 | 3.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.4 | 1.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.4 | 0.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 2.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 2.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.1 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.4 | 1.4 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 1.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 2.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 3.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 4.6 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.4 | 1.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 0.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.4 | 1.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 1.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 2.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 3.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 0.7 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.3 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 3.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 1.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.7 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 1.0 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 1.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 1.0 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 0.3 | GO:2001270 | positive regulation of endodeoxyribonuclease activity(GO:0032079) regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.3 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 2.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 2.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 1.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 1.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.3 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 3.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 1.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 1.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 2.9 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.3 | 2.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 2.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 4.8 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 0.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.3 | 1.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 3.2 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.3 | 3.8 | GO:0032438 | melanosome organization(GO:0032438) |
0.3 | 2.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 3.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 1.6 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.3 | 1.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 0.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 1.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 3.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 1.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.3 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.3 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 0.9 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 2.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 2.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.3 | 1.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 2.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 0.6 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.3 | 0.6 | GO:0060620 | sterol import(GO:0035376) regulation of cholesterol import(GO:0060620) cholesterol import(GO:0070508) regulation of sterol import(GO:2000909) |
0.3 | 3.0 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 3.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 0.6 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.3 | 2.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 1.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 2.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 4.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 3.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.9 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.9 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 0.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 0.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 1.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.3 | 0.9 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 4.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 1.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.3 | 2.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 2.0 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.3 | 0.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 2.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 7.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.3 | 0.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 0.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 2.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.9 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.3 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.3 | 2.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 2.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 1.7 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 0.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 0.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 1.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 7.0 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 1.9 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 0.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 1.9 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 4.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 1.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 1.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 0.5 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 6.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 1.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.8 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.3 | 0.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 0.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 3.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.3 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 1.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 0.5 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 0.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 2.6 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.3 | 1.0 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.3 | 2.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 5.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 1.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 4.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 0.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 0.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 3.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 4.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.3 | 1.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 0.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 0.8 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 0.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 0.8 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.3 | 2.3 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.3 | 2.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 0.5 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 4.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 4.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 1.7 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.7 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 1.2 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.2 | 0.7 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 1.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 1.0 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.2 | 1.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 2.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 2.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.5 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 1.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 1.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 1.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 2.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.2 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 2.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 7.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.2 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 2.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 1.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 3.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.7 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 3.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.2 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 6.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.5 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 6.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 2.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 4.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.7 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 2.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.2 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.2 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 2.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 1.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.9 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 1.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 1.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 1.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.9 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 3.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 2.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 3.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 2.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.9 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 1.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 0.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 2.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 1.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.6 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.6 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.5 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.2 | 0.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.2 | 1.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 3.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 5.3 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 1.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.2 | 0.8 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 5.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 7.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 7.1 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.2 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 1.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 4.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.2 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 1.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 2.5 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 1.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.4 | GO:0090160 | regulation of natural killer cell degranulation(GO:0043321) Golgi to lysosome transport(GO:0090160) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 1.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 2.0 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.2 | 5.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 2.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 1.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.2 | GO:0071504 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) response to heparin(GO:0071503) cellular response to heparin(GO:0071504) regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.2 | 1.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.5 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 2.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.4 | GO:0097531 | mast cell migration(GO:0097531) |
0.2 | 3.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 1.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.6 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.2 | 0.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.2 | 0.2 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.2 | 0.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 3.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 6.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.3 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.9 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.2 | 0.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 1.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.7 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 1.9 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.5 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 0.5 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.2 | 1.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 6.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 1.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 2.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 1.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 4.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 3.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.2 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.2 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.2 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.2 | 1.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 1.0 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.2 | 1.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 1.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.2 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.2 | 0.5 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.8 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 1.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 2.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.2 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.6 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 1.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.3 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 5.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 5.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal absorption(GO:0070293) renal sodium ion absorption(GO:0070294) |
0.2 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.5 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 1.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.1 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 5.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 3.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.6 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 2.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.9 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.8 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.4 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 1.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 1.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 1.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.8 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.5 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 2.4 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 3.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 4.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.9 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 8.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 3.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 3.2 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.1 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.7 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.1 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 3.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 1.0 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 2.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 2.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 1.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 1.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.0 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 1.7 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.8 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 2.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.1 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 2.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.9 | GO:0016573 | histone acetylation(GO:0016573) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 19.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.2 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 2.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.5 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.1 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 1.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 4.0 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.5 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 2.0 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 4.5 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 0.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.4 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 2.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 2.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.1 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.8 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 3.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 4.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.9 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.9 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.4 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0072677 | eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.1 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.2 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.1 | 0.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 1.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.6 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.3 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.6 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.1 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 2.2 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.1 | GO:0071825 | protein-lipid complex subunit organization(GO:0071825) |
0.1 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.1 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.4 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.1 | 0.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 0.9 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.3 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.2 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 2.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.1 | 0.5 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 2.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.2 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.5 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.9 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 1.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 1.6 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.4 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 2.8 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.7 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 1.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.2 | GO:0016577 | histone demethylation(GO:0016577) histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.7 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.4 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 5.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.0 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.7 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 2.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.2 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.0 | GO:0045924 | regulation of female receptivity(GO:0045924) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0071865 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.0 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 1.7 | GO:0098542 | defense response to other organism(GO:0098542) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 0.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0009118 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.0 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.0 | 0.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.7 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:0009309 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0051354 | regulation of endodeoxyribonuclease activity(GO:0032071) negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.5 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.6 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.0 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.0 | GO:1901568 | icosanoid metabolic process(GO:0006690) unsaturated fatty acid metabolic process(GO:0033559) fatty acid derivative metabolic process(GO:1901568) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 5.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.1 | 3.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.1 | 3.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 3.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 4.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.0 | 2.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.9 | 2.8 | GO:0044393 | microspike(GO:0044393) |
0.9 | 5.6 | GO:0002102 | podosome(GO:0002102) |
0.9 | 5.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 2.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 4.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 4.2 | GO:0005638 | lamin filament(GO:0005638) |
0.8 | 3.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 2.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 1.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.8 | 8.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 3.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 3.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.7 | 5.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 2.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 2.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 6.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 2.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 2.7 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 1.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 3.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 3.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 3.2 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 6.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 2.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 2.4 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 1.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 2.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 2.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 3.4 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 2.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 2.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 1.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 4.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 2.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 3.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 2.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 3.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 2.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 5.0 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 5.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 4.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 1.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 3.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 6.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 2.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 1.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 2.8 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.5 | 3.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.8 | GO:0030891 | VCB complex(GO:0030891) |
0.4 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 1.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 2.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 1.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 18.9 | GO:0005844 | polysome(GO:0005844) |
0.4 | 2.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 1.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 2.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 1.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 2.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 5.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 4.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 5.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 1.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 1.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 2.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 10.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 1.1 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 4.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 6.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 7.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 1.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 2.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 1.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 11.7 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 22.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 4.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 3.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 3.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 3.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 1.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 6.7 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 0.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 4.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 14.1 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 3.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 1.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.3 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 8.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 6.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 8.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.8 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 25.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.2 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.3 | 2.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 12.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 2.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 9.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.3 | 5.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 7.0 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 0.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 2.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.3 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 2.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 0.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 5.0 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 8.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 2.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 4.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.7 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 1.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.9 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 1.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 14.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 2.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 9.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 3.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 3.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 9.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.4 | GO:0036452 | ESCRT complex(GO:0036452) |
0.2 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 2.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 2.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 2.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 7.9 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 2.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 2.5 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 2.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.2 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 9.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 0.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 17.5 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 9.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 1.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.5 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.6 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 2.0 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 3.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 46.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 4.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 5.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 8.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 2.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.8 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 12.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 4.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.1 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 2.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 10.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 56.7 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 8.3 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 4.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 3.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.5 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 3.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 7.4 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 2.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 11.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 2.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 9.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 21.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 67.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 3.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 2.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 61.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 7.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 4.1 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 3.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 5.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.1 | GO:0046930 | membrane attack complex(GO:0005579) pore complex(GO:0046930) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 1.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 37.6 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 4.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 1.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 5.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 2.0 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 34.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 31.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 11.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.5 | 10.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.3 | 13.8 | GO:0004064 | arylesterase activity(GO:0004064) |
1.7 | 11.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.5 | 6.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 7.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.5 | 4.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.4 | 5.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.3 | 5.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.3 | 4.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.3 | 6.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
1.3 | 5.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 4.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.2 | 2.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.2 | 8.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.2 | 4.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.1 | 4.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.1 | 3.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.1 | 1.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.1 | 9.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.0 | 8.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.9 | 2.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.9 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 2.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.9 | 2.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.9 | 2.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 3.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 2.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.9 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.9 | 4.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.9 | 2.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 5.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 2.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 2.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 3.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.8 | 8.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 4.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 2.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.8 | 3.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.8 | 2.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 0.8 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.7 | 3.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 2.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 2.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.7 | 2.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 2.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 1.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.7 | 2.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 8.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 3.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 2.7 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 2.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 3.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 13.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 3.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 1.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 1.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 3.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 2.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 1.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.6 | 1.8 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 4.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 1.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.6 | 4.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 4.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 2.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 2.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 2.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 0.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 5.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 2.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 3.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 2.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.5 | 1.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.5 | 1.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 6.0 | GO:0052839 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.5 | 2.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 1.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 3.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 4.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 3.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 1.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 1.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 1.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 2.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 2.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 4.1 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 1.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.5 | 3.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.5 | 6.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 4.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.5 | 2.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 2.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.5 | 2.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 3.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 1.5 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 6.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 2.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 1.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 1.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 1.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 1.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.5 | 2.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 3.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 0.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.5 | 1.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 0.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.5 | 1.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 3.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 1.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 1.8 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 15.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 5.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 1.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 3.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 3.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 2.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 2.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 2.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 2.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 2.1 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 0.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.4 | 2.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 4.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 2.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 3.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 1.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 1.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 2.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 2.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 1.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 2.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 2.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 0.8 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 4.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 1.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 1.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 2.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 1.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 4.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.4 | 4.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.4 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 3.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 2.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 2.1 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 1.4 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 6.2 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 2.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 4.1 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 3.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 4.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 7.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 1.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 1.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 1.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 2.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 6.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 2.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 4.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 2.2 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 4.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 1.9 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 4.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 3.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 1.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 5.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 9.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 1.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 2.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 4.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 3.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.5 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.3 | 4.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.9 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 8.0 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 2.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 8.4 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 2.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 3.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 2.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 6.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 3.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.8 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 3.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 5.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 4.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 1.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 5.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 1.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 3.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 0.8 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.3 | 2.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 8.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 3.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 2.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 5.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 4.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 3.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 1.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 0.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 2.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 5.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 1.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 2.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 2.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 3.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 14.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 2.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 1.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 3.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 4.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 4.9 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 1.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 1.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.7 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 6.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 6.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 3.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 7.0 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 0.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 2.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 2.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 2.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 1.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 4.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 2.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 6.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 1.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 21.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.8 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 7.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 3.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 4.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 2.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 16.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 3.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 2.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 8.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 3.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 2.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 7.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 5.4 | GO:0018733 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 3.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 0.8 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 2.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 16.8 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.6 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 1.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 9.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 3.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.6 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 4.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 3.1 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 1.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 5.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 10.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.9 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 3.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 2.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 2.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 3.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 1.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 5.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 4.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 4.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 12.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 1.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 6.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 1.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 1.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.3 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 10.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.4 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 3.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 13.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 3.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 1.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 3.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 3.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 4.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 1.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 2.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 9.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 50.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.5 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 4.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 4.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.6 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 3.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 2.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 2.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 1.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.8 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 6.1 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 12.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 1.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 2.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 1.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 1.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.4 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 1.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 2.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 1.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 12.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 9.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 24.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 15.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 12.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 12.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 6.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 5.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 12.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 2.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 2.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 6.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 18.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 4.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 3.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 3.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 8.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 6.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 4.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 6.9 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 3.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 5.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 5.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 10.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 18.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 3.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 2.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 3.7 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 3.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 5.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 1.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 3.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 8.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 7.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 8.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 4.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 6.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 7.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 9.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 3.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 4.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 2.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 12.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 2.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 3.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 4.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 4.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.3 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 9.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 3.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 14.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.1 | 10.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 13.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 0.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 7.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 7.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 14.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 6.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 5.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 3.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 8.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 10.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 7.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 7.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 2.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 9.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 1.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.5 | 3.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 9.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 3.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 5.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 5.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 4.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 3.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 8.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 4.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 16.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 5.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 11.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 3.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 3.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 7.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 5.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 3.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 3.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 3.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 5.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 2.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 2.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 7.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 8.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 3.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 3.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 6.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 7.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.3 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 5.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 9.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 3.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 5.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 5.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 13.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 4.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 28.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 1.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 6.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 4.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.3 | 4.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 3.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 2.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 5.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 1.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 4.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 0.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 3.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 3.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 8.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 1.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 4.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 13.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 15.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 3.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 3.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 11.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 3.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 7.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 5.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 7.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 6.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 10.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 4.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 3.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 15.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 6.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 4.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 1.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 4.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 1.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 4.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.2 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 1.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 1.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 2.4 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.2 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 7.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 22.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 3.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 4.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 13.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 4.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 6.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 2.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 2.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 2.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.6 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.6 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.8 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 1.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |